American Diabetes Association June 2010
Abstracts
Insulin Antibodies Associated With Technosphere® Insulin
W. Yu, M. Marino, J. Cassidy, A. H. Boss, S. E. Fineberg
2010 ADA Abstract W.Yu.
A1C and Hypoglycemia in Patients With Type 2 Diabetes Mellitus Incorporating Prandial Inhaled Technosphere Insulin Into Their Usual Antihyperglycemic Regimen vs Continuing Their Usual Antihyperglycemic Regimen
P. Raskin, M. Phillips, A. Rossiter, A. H. Boss, P. C. Richardson
2010 ADA Abstract P.Raskin
Easy-to-Use Next-Generation Pulmonary Insulin Delivery System
C. C. Smutney, J. M. Polidoro
2010 ADA Abstract C.Smutney
Improvements Realized in a Next-Generation Pulmonary Insulin Delivery System
C. C. Smutney, J. M. Polidoro
2010 ADA Abstract C.Smutney
A Pharmacokinetic/Pharmacodynamic Model of Inhaled Insulin with Application to Clinical Trial Simulation
M. T. Marino
2010 ADA Abstract M.Marino
Posters
Insulin Kinetics Following Technosphere® Insulin Inhalation Powder Administration Unchanged in Albuterol-Treated Asthmatics
J. Cassidy, N. Amin, R. Baughman, C. Clarke, R. Mills, D. Singh, P. Haworth, A. H. Boss, P. C. Richardson
2010 ADA Poster J.Cassidy LR
Technosphere® Insulin: Safety in Type 2 Diabetes Mellitus
A. Rossiter, C. Howard, N. Amin, D. Costello, A. H. Boss
ADA Poster A.Rossiter LR
A Phase 1, Open-Label Study of the Effect of Albuterol or Fluticasone on the Pharmacokinetics of Inhaled Technosphere® Insulin Inhalation Powder in Healthy Subjects
R. Baughman, J. Cassidy, N. Amin, M. Hompesch, M. Marino, P. Haworth, P. Richardson
2010 ADA Poster R.Baughman LR
In Patients Using Technosphere® Insulin Variation in PPG Stayed Within ADA Recommended Targets Despite Large Variations in Glucose Load
H. Zisser, J. Hone, L. Jovanovic, R. Petrucci, A. H. Boss, P. Richardson, A. Mann
2010 ADA Poster H.Zisser LR
A Population PK/PD Model of Technosphere® Insulin Administered to Healthy and Type 2 Diabetic Subjects
E. Potocka, R. A. Baughman, Jr., H. Derendorf
2010 ADA Poster E.Potocka LR
Characterization of Metabolism Parameters Following Technosphere® Insulin and Insulin Lispro
E. Potocka, R. Hovorka, R. Baughman, O. Klein, S. Dellweg, M. Umpleby, P. Haworth, R. Mills, A. H. Boss, P. C. Richardson
2010 ADA Poster E.Potocka LR
Perceived Medication Benefits and their Association with Interest in Using Inhaled Insulin in Type 2 Diabetes: A Model of Patients’ Cognitive Framework
M. Peyrot, R. R. Rubin
2010 ADA Poster M.Peyrot LR
Oral Presentation
Insulin Antibodies Associated with Technosphere® Insulin (TI)
Wen Yu, Mark T. Marino, James P. Cassidy, Anders H. Boss, Samuel Fineberg
|
